Literature DB >> 6373145

The enzymology of skeletal muscle disorders.

J A Lott, P W Landesman.   

Abstract

In myopathic disorders, abnormal serum enzyme activities are seen primarily in diseases of skeletal muscle where the condition involves the muscle fibers themselves. In denervation myopathies, serum enzyme activities are usually normal. The most dramatic increases of serum enzymes, particularly creatine kinase, are found in the dystrophic diseases, particularly Duchenne dystrophy. A review is given here of the many causes of abnormal serum enzyme activities where the source of enzymes is believed to be skeletal muscle. These include the dystrophies, various types of trauma, exercise, drug- and poison-induced causes including alcohol, malignant hyperthermia, inflammatory diseases, and miscellaneous causes. Tissue and serum activities are summarized for the commonly performed serum enzymes, i.e., CK, LD, AST, and aldolase. An extensive tabular and current description of the various types of dystrophies is given along with serum CK and pyruvate kinase activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373145     DOI: 10.3109/10408368409165773

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  11 in total

1.  Alanine aminotransferase regulation by androgens in non-hepatic tissues.

Authors:  Christopher C Coss; Matt Bauler; Ramesh Narayanan; Duane D Miller; James T Dalton
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  Race-gender differences in serum creatine kinase activity: a study among South Africans.

Authors:  R F Gledhill; C A Van der Merwe; M Greyling; M M Van Niekerk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

Review 3.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells.

Authors:  Livia Casciola-Rosen; John C Hall; Andrew L Mammen; Lisa Christopher-Stine; Antony Rosen
Journal:  Clin Exp Rheumatol       Date:  2012-08-29       Impact factor: 4.473

5.  Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors.

Authors:  L W Kundrotas; D J Clement
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

6.  Serum alanine aminotransferase is correlated with hematocrit in healthy human subjects.

Authors:  Yun Hu; Soren Snitker; Kathleen A Ryan; Rongze Yang; Braxton D Mitchell; Alan R Shuldiner; Dalong Zhu; Da-Wei Gong
Journal:  Scand J Clin Lab Invest       Date:  2012-05       Impact factor: 1.713

7.  Biochemical diagnosis of liver disease.

Authors:  P L Wolf
Journal:  Indian J Clin Biochem       Date:  1999-01

8.  Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.

Authors:  Esperanza Gonzalez; Sebastiaan van Liempd; Javier Conde-Vancells; Virginia Gutierrez-de Juan; Miriam Perez-Cormenzana; Rebeca Mayo; Agustin Berisa; Cristina Alonso; Cesar A Marquez; Jonathan Barr; Shelly C Lu; Jose M Mato; Juan M Falcon-Perez
Journal:  Metabolomics       Date:  2011-07-14       Impact factor: 4.290

9.  Alterations in protein and amino acid metabolism in rats fed a branched-chain amino acid- or leucine-enriched diet during postprandial and postabsorptive states.

Authors:  Milan Holecek; Pavel Siman; Melita Vodenicarovova; Roman Kandar
Journal:  Nutr Metab (Lond)       Date:  2016-02-11       Impact factor: 4.169

10.  Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation.

Authors:  Anna M L Coenen-Stass; Corinne A Betts; Yi F Lee; Imre Mäger; Mikko P Turunen; Samir El Andaloussi; Jennifer E Morgan; Matthew J A Wood; Thomas C Roberts
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.